Vnitr Lek 2020, 66(2):92-96 | DOI: 10.36290/vnl.2020.015

Diabetic foot

Robert Bém, Michal Dubský, Vladimíra Fejfarová, Jitka Husáková, Veronika Wosková
Centrum diabetologie, Institut klinické a experimentální medicíny, Praha

Diabetic foot (DF) is a serious late complication of diabetes associated with high morbidity and mortality, often leading to lower limb amputation. Risk factors for DF include neuropathy, infection, and ischemia. The prevention of ulceration is essential for reducing amputation rate. Effective follow-up of patients and application of preventive approaches such as using of appropriate shoes and foot care can reduce the incidence of ulcerations by up to 50 %. DF treatment is very expensive and includes offloading of the affected foot, treatment of infection and revascularization. Local treatment and satisfactory diabetes control are also very important. Professional care for these patients should be directed to specialized podiatric clinics due to the need for a multidisciplinary approach.

Keywords: diabetes mellitus, diabetic foot, amputation.

Published: April 2, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bém R, Dubský M, Fejfarová V, Husáková J, Wosková V. Diabetic foot. Vnitr Lek. 2020;66(2):92-96. doi: 10.36290/vnl.2020.015.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Apelqvist J, Bakker K, van Houtum WH, Schaper NC. The development of global consensus guidelines on the management of the diabetic foot. Diabetes/metabolism research and reviews. 2008; 24 Suppl 1: S116-118. Go to original source... Go to PubMed...
    2. van Netten JJ, Bus SA, Apelqvist J, et al. Definitions and criteria for diabetic foot disease. Diabetes/metabolism research and reviews. 2020: e3268. Go to original source... Go to PubMed...
    3. Prompers L, Huijberts M, Schaper N, et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51(10): 1826-1834. Go to original source... Go to PubMed...
    4. Vadiveloo T, Jeffcoate W, Donnan PT, et al. Amputation‑free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study. Diabetologia. 2018;61(12): 2590-2597. Go to original source... Go to PubMed...
    5. Lavery LA, Oz OK, Bhavan K, Wukich DK. Diabetic Foot Syndrome in the Twenty‑First Century. Clinics in podiatric medicine and surgery. 2019; 36(3): 355-355. Go to original source... Go to PubMed...
    6. Buldt AK, Menz HB. Incorrectly fitted footwear, foot pain and foot disorders: a systematic search and narrative review of the literature. Journal of foot and ankle research. 2018; 11: 43. Go to original source... Go to PubMed...
    7. van Netten JJ, Raspovic A, Lavery LA, et al. Prevention of foot ulcers in the at‑risk patient with diabetes: a systematic review. Diabetes/metabolism research and reviews. 2020: e3270. Go to original source... Go to PubMed...
    8. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. The New England journal of medicine. 2017; 376(24): 2367-2375. Go to original source... Go to PubMed...
    9. Jeffcoate WJ, Vileikyte L, Boyko EJ, Armstrong DG, Boulton AJM. Current Challenges and Opportunities in the Prevention and Management of Diabetic Foot Ulcers. Diabetes care. 2018; 41(4): 645-652. Go to original source... Go to PubMed...
    10. Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007; 50(1): 18-25. Go to original source... Go to PubMed...
    11. Pop‑Busui R, Boulton AJ, Feldman EL, et al. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes care. 2017; 40(1): 136-154. Go to original source... Go to PubMed...
    12. Engberg S, Kirketerp‑Moller K, Ullits Andersen H, Rasmussen A. Incidence and predictors of recurrent and other new diabetic foot ulcers: a retrospective cohort study. Diabetic medicine : a journal of the British Diabetic Association. 2019; 36(11): 1417-1423. Go to original source... Go to PubMed...
    13. Joret MO, Osman K, Dean A, Cao C, van der Werf B, Bhamidipaty V. Multidisciplinary clinics reduce treatment costs and improve patient outcomes in diabetic foot disease. Journal of vascular surgery. 2019; 70(3): 806-814. Go to original source... Go to PubMed...
    14. Gotz J, Lange M, Dullien S, et al. Off‑loading strategies in diabetic foot syndrome‑evaluation of different devices. International orthopaedics. 2017; 41(2): 239-246. Go to original source... Go to PubMed...
    15. Bus SA, van Deursen RW, Armstrong DG, Lewis JE, Caravaggi CF, Cavanagh PR. Footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic review. Diabetes/metabolism research and reviews. 2016; 32 Suppl 1: 99-118. Go to original source... Go to PubMed...
    16. Pysna A, Bem R, Nemcova A, et al. Endothelial Progenitor Cells Biology in Diabetes Mellitus and Peripheral Arterial Disease and their Therapeutic Potential. Stem cell reviews and reports. 2019; 15(2): 157-165. Go to original source... Go to PubMed...
    17. Uckay I, Berli M, Sendi P, Lipsky BA. Principles and practice of antibiotic stewardship in the management of diabetic foot infections. Current opinion in infectious diseases. 2019; 32(2): 95-101. Go to original source... Go to PubMed...
    18. Lazaro Martinez JL, Garcia Alvarez Y, Tardaguila‑Garcia A, Garcia Morales E. Optimal management of diabetic foot osteomyelitis: challenges and solutions. Diabetes, metabolic syndrome and obesity : targets and therapy. 2019; 12: 947-959. Go to original source... Go to PubMed...
    19. Borys S, Hohendorff J, Koblik T, et al. Negative‑pressure wound therapy for management of chronic neuropathic noninfected diabetic foot ulcerations - short‑term efficacy and long‑term outcomes. Endocrine. 2018; 62(3): 611-616. Go to original source... Go to PubMed...
    20. Cerovsky V, Bem R. Lucifensins, the Insect Defensins of Biomedical Importance: The Story behind Maggot Therapy. Pharmaceuticals. 2014; 7(3): 251-264. Go to original source... Go to PubMed...
    21. Game FL, Apelqvist J, Attinger C, et al. Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes/metabolism research and reviews. 2016; 32 Suppl 1: 154-168. Go to original source... Go to PubMed...
    22. Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. Diabetes care. 2011; 34(9): 2123-2129. Go to original source... Go to PubMed...
    23. Schmidt BM, Holmes CM. Updates on Diabetic Foot and Charcot Osteopathic Arthropathy. Current diabetes reports. 2018; 18(10): 74. Go to original source... Go to PubMed...
    24. Richard JL, Almasri M, Schuldiner S. Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia. 2012; 55(5): 1258-1264. Go to original source... Go to PubMed...
    25. Raspovic KM, Liu GT, Lalli T, Van Pelt M, Wukich DK. Optimizing Results in Diabetic Charcot Reconstruction. Clinics in podiatric medicine and surgery. 2019; 36(3): 469-481. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.